Cytosorbents (CTSO) Earnings Date & Reports

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

CTSO is expected to report earnings to rise 116.67% to -6 cents per share on May 06

Cytosorbents CTSO Stock Earnings Reports

Q1'25

Est.

$-0.06

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.01

Q1'24

Beat

by $0.01

The last earnings report on March 31 showed earnings per share of -2 cents, beating the estimate of -5 cents. With 10.46K shares outstanding, the current market capitalization sits at 49.22M.

View a ticker or compare two or three

Compare

CTSO